What is Tiziana Life Sciences Ltd (TLSA)'s fair-value range?

EvidInvest reads Tiziana Life Sciences Ltd (TLSA)'s market price back into the assumptions behind it — the implied P/E, growth rate and cash yield — using its latest filed financials, then lets you set your own. See the full DCF, Graham number, EPV and multiple-based methods at https://evidinvest.com/valuation/TLSA.

How is Tiziana Life Sciences Ltd (TLSA)'s fair value calculated?

Tiziana Life Sciences Ltd (TLSA)'s fair value is computed with several independent methods — a discounted cash flow (DCF) model, the Graham number, earnings power value (EPV), and valuation multiples such as PE and EV/EBITDA — using data from SEC filings. P/B is optional for non-financial companies and included in the preset range for financial sectors.

Which filing are Tiziana Life Sciences Ltd (TLSA)'s valuation inputs based on?

Inputs come from the FY2025 20-F filed 2026-05-01 (accession 0001213900-26-051015). Source: https://www.sec.gov/Archives/edgar/data/1723069/000121390026051015/

Fair value · Tiziana Life Sciences Ltd (TLSA) · updated 2026-10-29 · from 20-F FY2025

Tiziana Life Sciences trades at $0.95. We are not reading assumptions out of that price: this is a depositary receipt and we cannot show whether its per-share figures are stated per ADS or per ordinary share, so these methods are withheld rather than shown at a scale we cannot verify.

Name: Tiziana Life Sciences Ltd (TLSA) valuation inputs and fair-value methods
Creator: EvidInvest
License: https://evidinvest.com/subscription-terms

Everything below is unaffected: the filed statements, the filing they came from, and TLSA’s growth history are all as reported.

Check another stock

Inputs come from the FY2025 20-F filed 2026-05-01 (accession 0001213900-26-051015); set your own on the sliders below. Research, not investment advice.

The filing behind these numbers

Tiziana Life Sciences Ltd

Revenue: $0
Diluted EPS: $-0.16
Free cash flow: $-12.9M; operating cash flow − capital expenditure
Diluted shares: 118.3M; weighted average

20-F FY2025 · fiscal year ended 2025-12-31 · filed 2026-05-01 · accession 0001213900-26-051015

Open this filing on sec.gov

Valuation tool: build your own TLSA range

Fair Value Summary

Daily Price — TLSA

$0.95 -51.3% (1Y)

Your range0 of 7 methods

At least two methods need a usable value to draw a range with these inputs.

Range with preset inputs

No preset range for this company yet.

The two ranges are identical because every input sits on a preset.

We don’t tell you what TLSA is worth. Every tab OPENS on what today’s price implies for that method’s key assumption; you decide whether that assumption is reasonable — the growth matrix has TLSA’s filed history and the AI chat will reason it through with you — and the range you build is yours. Our presets are filed history and reference settings, never a recommendation.

Discounted cash flow

N/A

This is a depositary receipt and we cannot show whether its per-share figures are stated per ADS or per ordinary share, so these methods are withheld rather than shown at a scale we cannot verify.

Preset inputs — revenue-driven DCF from the latest filing

Implied by today’s price

This is a depositary receipt and we cannot show whether its per-share figures are stated per ADS or per ordinary share, so these methods are withheld rather than shown at a scale we cannot verify.

Not solvable from the price — This is a depositary receipt and we cannot show whether its per-share figures are stated per ADS or per ordinary share, so these methods are withheld rather than shown at a scale we cannot verify. Showing preset inputs.

This method has no key input to read out of the price. The others below do, and you set them yourself: the growth matrix shows what TLSA has actually filed, and the AI chat will reason it through with you.

Your inputs

Free cash flow grows at your stage-1 rate, then your stage-2 rate, then a terminal rate; everything is discounted at your WACC.

Stage-1 growth5.0%

Yearly free-cash-flow growth for the first stage. Starts below zero so a shrinking-cash-flow case — and the rate today’s price implies — can be set.

-20.0%60.0%

Stage-1 years5 yrs

How long stage-1 growth lasts.

1 yrs10 yrs

Stage-2 growth2.5%

Slower growth after stage 1, before the terminal phase.

-20.0%30.0%

Stage-2 years5 yrs

0 yrs10 yrs

Terminal growth2.5%

Growth forever after the two stages. Above ~3% is rarely justified.

0.0%5.0%

Discount rate (WACC)4.29%

The return you require. Default is the WACC EvidInvest computed for this company. Higher discount rate, lower value.

3.00%15.00%

Net debt ($M)Debt minus cash, from the balance sheet. Subtracted from enterprise value.

Starting FCF ($M)Latest free cash flow from the filing (operating cash flow minus capex).

Shares (M)Diluted shares, from the filing.

Year by year (two-stage model, $M)

PV explicit $-130M · PV terminal $-706M · EV $-836M · equity $-832M

Year	Stage	FCF	Present value
1	Stage 1	$-14M	$-13M
2	Stage 1	$-14M	$-13M
3	Stage 1	$-15M	$-13M
4	Stage 1	$-16M	$-13M
5	Stage 1	$-17M	$-13M
6	Stage 2	$-17M	$-13M
7	Stage 2	$-17M	$-13M
8	Stage 2	$-18M	$-13M
9	Stage 2	$-18M	$-13M
10	Stage 2	$-19M	$-12M

Inputs from the filing

Free cash flow: $-12.9M; latest full year
EBIT: $-21.1M; latest annual
Shares: 118.3M
Total debt: $456000
Cash: $4.0M
Net debt: $-3.6M; debt − cash

20-F FY2025 · period ended 2025-12-31 · filed 2026-05-01 · accession 0001213900-26-051015 · sec.gov

Prefer a blank slate with reverse DCF? Open the standalone DCF / reverse DCF for TLSA

Loading history...

Tiziana Life Sciences trades at $0.95. We are not reading assumptions out of that price: this is a depositary receipt and we cannot show whether its per-share figures are stated per ADS or per ordinary share, so these methods are withheld rather than shown at a scale we cannot verify.

The filing behind these numbers

Valuation tool: build your own TLSA range

Daily Price — TLSA

Your range0 of 7 methods

Range with preset inputs

Your inputs

Year by year (two-stage model, $M)

More on TLSA

Compare with peers

Explore

Valuation tool: build your own TLSA range

Daily Price — TLSA

Your range0 of 7 methods

Range with preset inputs

Your inputs

Year by year (two-stage model, $M)

More on TLSA

Compare with peers

Explore